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Abstract
Progress in understanding core pathways and processes of cancer requires thorough
analysis of many coding and noncoding regions of the genome. Data mining and
knowledge discovery have been applied to datasets across many industries, including
bioinformatics. However, data mining faces a major challenge in its application to
bioinformatics: the diversity and dimensionality of biomedical data. The term ’big
data’ was applied to the clinical domain by Yoo et al. (2014), specifically referring
to single nucleotide polymorphism (SNP) and gene expression data. This research
thesis focuses on three different types of data: gene-annotations, gene expression and
single nucleotide polymorphisms.
Genetic association studies have led to the discovery of single genetic variants
associated with common diseases. However, complex diseases are not caused by a
single gene acting alone but are the result of complex linear and non-linear interactions
among different types of microarray data. In this scenario, a single gene can have a
small effect on disease but cannot be the major cause of the disease. For this reason
there is a critical need to implement new approaches which take into account linear
and non-linear gene-gene and patient-patient interactions that can eventually help in
diagnosis and prognosis of complex diseases. Several computational methods have
been developed to deal with gene annotations, gene expressions and SNP data of
1
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complex diseases. However, analysis of every gene expression and SNP profile, and
finding gene-to-gene relationships, is computationally infeasible because of the high-
dimensionality of data. In addition, many computational methods have problems with
scaling to large datasets, and with overfitting. Therefore, there is growing interest in
applying data mining and machine learning approaches to understand different types
of microarray data.
Cancer is the disease that kills the most children in Australia (Torre et al., 2015).
Within this thesis, the focus is on childhood Acute Lymphoblastic Leukaemia. Acute
Lymphoblastic Leukaemia is the most common childhood malignancy with 24% of all
new cancers occurring in children within Australia (Coates et al., 2001). According
to the American Cancer Society (2016), a total of 6,590 cases of ALL have been
diagnosed across all age groups in USA and the expected deaths are 1,430 in 2016.
The project uses different data mining and visualisation methods applied on dif-
ferent types of biological data: gene annotations, gene expression and SNPs.
This thesis focuses on three main issues in genomic and transcriptomic data stud-
ies:
(i) Proposing, implementing and evaluating a novel framework to find functional
relationships between genes from gene-annotation data.
(ii) Identifying an optimal dimensionality reduction method to classify between
relapsed and non-relapsed ALL patients using gene expression.
(iii) Proposing, implementing and evaluating a novel feature selection approach to
identify related metabolic pathways in ALL
Abstract 3
This thesis proposes, implements and validates an efficient framework to find func-
tional relationships between genes based on gene-annotation data. The framework is
built on a binary matrix and a proximity matrix, where the binary matrix contains
information related to genes and their functionality, while the proximity matrix shows
similarity between different features.The framework retrieves gene functionality infor-
mation from Gene Ontology (GO), a publicly available database, and visualises the
functional related genes using singular value decomposition (SVD). From a simple list
of gene-annotations, this thesis retrieves features (i.e Gene Ontology terms) related
to each gene and calculates a similarity measure based on the distance between terms
in the GO hierarchy. The distance measures are based on hierarchical structure of
Gene Ontology and these distance measures are called similarity measures. In this
framework, two different similarity measures are applied:
(i) A hop-based similarity measure where the distance is calculated based on the
number of links between two terms.
(ii) An information-content similarity measure where the similarity between terms
is based on the probability of GO terms in the gene dataset.
This framework also identifies which method performs better among these two sim-
ilarity measures at identifying functional relationships between genes. Singular value
decomposition method is used for visualisation, having the advantage that multiple
types of relationships can be visualised simultaneously (gene-to-gene, term-to-term
and gene-to-term)
In this thesis a novel framework is developed for visualizing patient-to-patient
relationships using gene expression values. The framework builds on the random forest
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feature selection method to filter gene expression values and then applies different
linear and non-linear machine learning methods to them. The methods used in this
framework are Principal Component Analysis (PCA), Kernel Principal Component
Analysis ( kPCA), Local Linear Embedding (LLE), Stochastic Neighbour Embedding
(SNE) and Diffusion Maps. The framework compares these different machine learning
methods by tuning different parameters to find the optimal method among them.
Area under the curve (AUC) is used to rank the results and SVM is used to classify
between relapsed and non-relapsed patients.
The final section of the thesis proposes, implements and validates a framework to
find active metabolic pathways in ALL using single nucleotide polymorphism (SNP)
profiles. The framework is based on the random forest feature selection method.
A collected dataset of ALL patient and healthy controls is constructed and later
random forest is applied using different parameters to find highly-ranked SNPs. The
credibility of the model is assessed based on the error rate of the confusion matrix
and kappa values. Selected high ranked SNPs are used to retrieve metabolic pathways
related to ALL from the KEGG metabolic pathways database.
The methodologies and approaches presented in this thesis emphasise the critical
role that different types of microarray data play in understanding complex diseases
like ALL. The availability of flexible frameworks for the task of disease diagnosis and
prognosis, as proposed in this thesis, will play an important role in understanding the
genetic basis to common complex diseases.
This thesis contributes to knowledge in two ways:
(i) Providing novel data mining and visualisation frameworks to handle biological
data.
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(ii) Providing novel visualisations for microarray data to increase understanding of
disease.
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Abbreviations and Glossary
Term Abbreviation Definition
Acute Lymphoblastic Leukaemia ALL
Biased data Data where cases of one class is very
high compared to other class
Classification A supervised learning process of assign-
ing cases to target class
Data transformation A process to transform or consolidate
data for effective use
Diffusion Maps DM
Dimensionality reduction Reducing the number of random vari-
ables in a dataset
Gene Ontology GO
High dimensionality Data whose dimension is higher than
dimensions considered in traditional
multivariate analysis
Kernel Principal Component
Analysis
kPCA
Kyoto Encyclopaedia of Genes
and Genomes
KEGG
Local Linear Embedding LLE
Nonlinear Dimensionality Reduc-
tion
NLDR
Prediction The process of predicting the outcome
of certain case
Principal Component Analysis PCA
Prognosis Predicting likely outcome of patient
Random Forest RF
Singular Value Decomposition SVD
Single Nucleotide Polymorphism SNPs
Stochastic Neighbour Embedding SNE
